BioCardia, Inc. (BCDA) vs Citius Pharmaceuticals, Inc. (CTXR)
BioCardia, Inc. and Citius Pharmaceuticals, Inc. are both Biotechnology companies. BioCardia, Inc. and Citius Pharmaceuticals, Inc. are of similar size ($16.2M and $15.7M). Across the 11 metrics below, BioCardia, Inc. leads on 7 and Citius Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | BCDA | CTXR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,803.19%) | (64.51%) | (57.72%) |
| Return on assets | (214.47%) | (34.29%) | (49.22%) |
| Return on invested capital | 0.00% | (58.74%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack